Literature DB >> 33446250

Low expression of miR-142-3p promotes intervertebral disk degeneration.

Jianmin Xue1,2, Baoyang Hu1,2, Wenhua Xing2, Feng Li2, Zhi Huang2, Wenkai Zheng2, Bo Wang1,2, Yong Zhu3, Xuejun Yang4.   

Abstract

BACKGROUND: Intervertebral disk degeneration (IDD) is a degenerative disease characterized by cytoplasm loss and extracellular matrix degradation. Numerous evidence reported that miRNAs participated in IDD development. Nevertheless, the function of miR-142-3p in IDD development remains unknown. This study mainly explored the potential role and function of miR-142-3p in IDD development.
METHODS: One percent fetal bovine serum was used to induce the degeneration of ATDC5 cells, and miR-142-3p level was examined by qRT-PCR. Then, miR-142-3p mimic/inhibitor and its corresponding negative control were transfected into ATDC5 normal and degenerative cells. Viability, migration, invasion, apoptosis, cycle, Bax, Bcl-2, P62, and Beclin1 expression levels were assessed using CCK8, wound healing assay, annexin V-FITC/PI staining, western blot, and qRT-PCR, respectively.
RESULTS: The results revealed that the expression levels of MMP13, ADAMTS5, MMP3, and Col-X were increased as well as the expression levels of SOX-9 and Col-II were reduced in ATDC5 degenerative cells, indicating the degeneration model was constructed. We observed that miR-142-3p was decreased in ATDC5 degenerative cells and its suppression could promote ATDC5 cell degeneration. However, miR-142-3p overexpression could reverse the cell viability inhibition, as well as apoptosis and autophagy enhancement in ATDC5 degenerative cells.
CONCLUSIONS: Our results proved that miR-142-3p may play an important role in disk degeneration. Further animal study is needed to illustrate the role of the miR-142-3p in IDD development.

Entities:  

Keywords:  Cell behavior; Intervertebral disk degeneration; miR-142-3p

Mesh:

Substances:

Year:  2021        PMID: 33446250      PMCID: PMC7809750          DOI: 10.1186/s13018-020-02194-4

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  29 in total

Review 1.  Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.

Authors:  Arthur Winer; Sylvia Adams; Paolo Mignatti
Journal:  Mol Cancer Ther       Date:  2018-05-07       Impact factor: 6.261

2.  MicroRNA-223 inhibits lipopolysaccharide-induced inflammatory response by directly targeting Irak1 in the nucleus pulposus cells of intervertebral disc.

Authors:  Hua Wang; Pan Hao; Hu Zhang; Cuiping Xu; Junyan Zhao
Journal:  IUBMB Life       Date:  2018-04-29       Impact factor: 3.885

Review 3.  MicroRNA in intervertebral disc degeneration.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2015-03-04       Impact factor: 6.831

4.  Therapeutic potential of microRNA in tendon injuries.

Authors:  Lorenzo Giordano; Giovanna Della Porta; Giuseppe M Peretti; Nicola Maffulli
Journal:  Br Med Bull       Date:  2020-05-15       Impact factor: 4.291

5.  MiR-499a-5p suppresses apoptosis of human nucleus pulposus cells and degradation of their extracellular matrix by targeting SOX4.

Authors:  Jing-Chuan Sun; Bing Zheng; Rong-Xin Sun; Ya-Ke Meng; Shun-Min Wang; Hai-Song Yang; Yu Chen; Jian-Gang Shi; Yong-Fei Guo
Journal:  Biomed Pharmacother       Date:  2019-03-08       Impact factor: 6.529

6.  Expression of type I, type II, and type X collagen genes during altered endochondral ossification in the femoral epiphysis of osteosclerotic (oc/oc) mice.

Authors:  A Yamasaki; M Itabashi; Y Sakai; H Ito; Y Ishiwari; H Nagatsuka; N Nagai
Journal:  Calcif Tissue Int       Date:  2001-02-23       Impact factor: 4.333

7.  The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis.

Authors:  Tomoyuki Nakasa; Hayatoshi Shibuya; Yoshihiko Nagata; Takuya Niimoto; Mitsuo Ochi
Journal:  Arthritis Rheum       Date:  2011-06

8.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

9.  Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-κB signaling.

Authors:  Jianhong Qiang; Tingting Lv; Zhenbiao Wu; Xichao Yang
Journal:  Biosci Rep       Date:  2019-07-08       Impact factor: 3.840

10.  Preclinical development of a microRNA-based therapy for intervertebral disc degeneration.

Authors:  Ming-Liang Ji; Hua Jiang; Xue-Jun Zhang; Pei-Liang Shi; Chao Li; Hao Wu; Xiao-Tao Wu; Yun-Tao Wang; Chen Wang; Jun Lu
Journal:  Nat Commun       Date:  2018-11-28       Impact factor: 14.919

View more
  1 in total

1.  Hyperoside ameliorates TNF‑α‑induced inflammation, ECM degradation and ER stress‑mediated apoptosis via the SIRT1/NF‑κB and Nrf2/ARE signaling pathways in vitro.

Authors:  Tian Xie; Jun Yuan; Ling Mei; Ping Li; Ruijie Pan
Journal:  Mol Med Rep       Date:  2022-06-22       Impact factor: 3.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.